Introduction {#sec1}
============

Turkey is the fifth largest producer (270.840 tons, 8%) and a significant consumer (6%) of sheep meat in the world ([@B6]; [@B15]). According to 2017 Turkish Statistical Institute (TSI) data, the sheep meat production rate is 9.16% (99,874 tons) of the total 1,089,747 tons of red meat produced in our country ([@B48]). Additionally, ovine meat (4.68 kg) accounts for almost one-third (28.66%) and 11.17% of annual 16.33 kg red meat and 41.89 kg overall per capita meat consumption, respectively ([@B16]). Apart from being one of the primary red meat sources, there is also high demand and use of sheep meat products and edible offal (88.320 tons/year, particularly liver, kidney, spleen, brain, intestines - as grilled sheep intestines - kokorec), with 1.18 kg of annual consumption per capita ([@B15]; [@B16]). Therefore, in our country, the welfare and hygienic slaughter of sheep play a substantial role in preventing transmissions of foodborne pathogens to meat and related food destined for human consumption, which has economic consequences for meat processors.

In European Union (EU), *Salmonella* is a frequently reported pathogen from bacterial gastroenteritis and outbreak cases in humans due to contaminated meat, meat products and edible offal. In particular, nontyphoid *Salmonella* (NTS), which has the most significant disease burden and foodborne deaths worldwide, in carcasses, internal organs and lymph nodes of slaughter sheep entering the food chain could be a substantial threat to public health ([@B11]). Common practices, such as transport, consignment in multiple groups before sale, and feed and water deprivation, could cause stress and increased shedding of the pathogen prior to slaughter ([@B2]; [@B53]). Thus, assessment of the NTS serovars and their antimicrobial resistances isolated from ovine carcasses is of critical value for farm-level biosafety measures and epidemiology. Additionally, the Turkish Food Codex (TFC) Regulation on Microbiological Criteria ([@B46]) has zero tolerance for the detection of *Salmonella* from ovine carcasses assessed with EN/ISO 6579 ([@B22]) as the reference method. Accordingly, several studies have reported *Salmonella* prevalence in sheep carcasses (0%--26.7%) ([@B28]; [@B39]; [@B42]), in fecal samples (0%--26.90%) ([@B8]; [@B19]; [@B34]), in edible organs such as liver (0.9%--4.3%) and spleen (0%--2.27%) ([@B28]; [@B36]; [@B52]), in gallbladder (3%) ([@B55]) and in mesenteric lymph nodes (3.85%--13.6%) ([@B19]; [@B28]; [@B43]), where *S*. Typhimurium was reported as the predominant serovar regardless of the sample type.

Currently, the TFC Regulation on Pharmacologically Active Substances and Their Classification Regarding Maximum Residue Limits in Foodstuffs of Animal Origin ([@B47]) requirements have become mandatory for food producers. One driving force for this requirement was the high resistance rates (in descending order) to tetracycline, ampicillin, chloramphenicol, amoxicillin/clavulanic acid, sulfamethoxazole/trimethoprim, cefoxitin, sulfisoxazole, and streptomycin antimicrobials in NTS isolates of human/animal origin and multidrug resistance (MDR) to at least two or more antimicrobials with rates ranging between 7.5%--82.35% observed in these resistant serovars. Additionally, almost one third of the isolates from humans were indicated to carry resistance to sulfonamides, ampicillin and tetracyclines, and showed 26.5% MDR to these 3 antimicrobials ([@B11]). Recent antimicrobial resistance studies related to the *Salmonella* isolates from slaughter sheep indicate high ampicillin resistance, subsequently resistance to sulfamethoxazole-trimethoprim, chloramphenicol, gentamicin, amoxicillin-clavulanic acid, ciprofloxacin and sulfonamide, in decreasing order ([@B8]; [@B10]; [@B21]; [@B36]; [@B41]). Therefore, infections with such resistant salmonellae isolated from foods of animal-origin could result in failures in management of public health risks.

In literature, there seems to be a scarcity of information on the current occurrence, serovar distribution and antimicrobial resistance of NTS in slaughter sheep and their offal in Turkey. Since ovine meat consumption has a considerably high share within red meat in Turkey, presence of NTS on carcasses and/or edible offal, or contamination of related products with this pathogen could be a significant threat to public health. Therefore, this study primarily focused on finding the NTS carrier rate of slaughter sheep, by using standard and internationally accepted methods, where real-time PCR aided in rapid identification and confirmation of the *Salmonella* suspect isolates. Further, the study aimed to identify the serovars circulating among these animals and to determine their antimicrobial resistance rates and patterns for epidemiological and preventive purposes.

Materials and Methods {#sec2}
=====================

Sample collection and preparation {#sec2-1}
---------------------------------

A total of 1,400 random samples comprised of 7 sample types (200 samples from each sample type) from carcass, fecal content, mesenteric lymph node, liver, kidney, spleen, and gallbladder were obtained from 200 sheep, which belonged to different herds, and slaughtered in 4 different slaughterhouses between 2013 and 2015. Sample collection strategy from above indicated sample types was applied in accordance with the requirements of the TFC ([@B46]) as follows: (1) Individual sterile sponges (Whirl Pak, B01351WA) wetted with buffered peptone water (BPW-ISO, Oxoid, CM1049) were used to wipe approximately a100 cm^2^ area from both sides of the abdomen, lateral thorax, crutch, and lateral breast of each carcass using a 10 cm×10 cm sterile square template, as instructed in the nondestructive sponge sampling method part of ISO 17604:2003 ([@B23]). (2) For fecal content collection, the methods indicated by [@B38] and [@B35] were applied, where the entire colonic and rectal content was stripped from the anus, carefully mixed, and about 25--50 g was placed into a sampling bag. (3) Mesenteric lymph nodes (3--5) were removed aseptically and collected into sampling bags as previously noted by [@B3]. (4) Areas around the portal vein and the orifice of ureter were rubbed by sterile swabs (LP Italiana, L111598) prewetted with BPW (ISO, Oxoid, CM1049) for liver and kidney samples, which were inserted into tubes containing 10 mL of sterile BPW ([@B31]), respectively. (5) The artery and vein openings on the renal surface of each spleen was swabbed with a prewetted swab to cover a 5 cm^2^ area, which was then placed into 10 mL of sterile BPW. (6) Gallbladders were sampled following the procedure described by [@B1], where the interior walls of the organ were rubbed with a BPW prewetted sterile swab, and placed into a tube containing 10 mL sterile BPW. All samples were transferred to the laboratory in icebox, and used in analyses within an hour.

Standard and quality control strains {#sec2-2}
------------------------------------

As positive controls, we used *S*. Typhimurium NCTC 12416 (Refik Saydam National Public Health Agency, Ankara, Turkey) and *S*. Enteritidis 64K (M.Y. Popoff, Institut Pasteur, Paris, France) in all tests. *Escherichia coli* ATCC 25922 strain was utilized as the strain for quality control in antimicrobial resistance tests ([@B13]).

Isolation and identification {#sec2-3}
----------------------------

For pre-enrichment of all sample types except fecal content was performed as follows: Carcass sponges and diced mesenteric lymph node samples close to 25 g, which were already in 25 mL BPW, were transferred into 225 mL BPW in individual 500 mL stomacher bags (LP Italiana, L177538). Liver, kidney, spleen and gallbladder swabs in 10 mL of BPW were allocated into stomacher bags containing 90 mL BPW. After a 2 min homogenization in a Stomacher Circulator (400C, Seward, West Sussex, UK) at 230 rpm, all samples were left for an 18 h incubation at 37°C. For selective enrichments, 1 and 0.1 mL of each pre-enrichment broth culture were inoculated into 10 mL of Mueller Kauffmann tetrathionate novobiocin (MKTTn, CM1048, Oxoid, Hampshire, UK) broth supplemented with novobiocin (SR0181, Oxoid) and into Rappaport-Vassiliadis soya peptone (RVS, CM0866, Oxoid) broth, and left for a 24 h incubation at 37°C and 41.5°C, respectively. Xylose lysine deoxycholate (XLD, CM0469, Oxoid) agar and brilliance salmonella (BS, CM1092, Oxoid) agar including Salmonella selective supplement (SR0194, Oxoid) were used in selective plating. After inoculation from both selective enrichment broths, all plates were incubated for 24 h at 35°C ([@B22]).

ISO 6579/A1: 2007 ([@B24]) requirements were followed in the processing of fecal content samples. Briefly, from the previously collected 50 g fecal content, a 25 g sample was weighed into a stomacher bag filled with 225 mL of BPW. This pre-enrichment mixture was then homogenized for 2 min at 230 rpm, and was incubated for 24 h at 37°C. Then, 0.1 mL aliquot from this pre-enrichment culture was dropped onto modified semisolid Rappaport-Vassiliadis (MSRV, CM1112, Oxoid) agar and incubated for 18--42 h at 41.5°C until a defined zone could be detected. A loopful of the growth zone was streaked onto xylose lysine tergitol-4 (XLT-4, CM1061, Oxoid), XLD, and BS agar plates, and left for 24 h incubation at 37°C. Then, 1--5 suspected colonies of *Salmonella* from these plates were inoculated onto MacConkey (MC, CM0115, Oxoid) agar for culture purification. This pure culture was used in *Salmonella* spp.-specific real-time PCR (RT-PCR) and in biotyping of the isolates. For RT-PCR template, we suspended pure culture from MC agar in sterile PCR-grade water (500 μL) which was then stored at −20°C. Urease activity test (Urea Agar Base, CM0053, Oxoid), triple sugar utilization and H~2~S formation test (Triple Sugar Iron Agar, CM0277, Oxoid), and lysine decarboxylase activity (Lysine Iron Agar, CM0381, Oxoid) test were used for initial biotyping. For these tests, the subcultured brain heart infusion broth (BHI, CM1135, Oxoid) (37°C, 18--20 h) of the pure culture grown on MC agar was used. The same culture was also used in further identification tests using API20E (20100, Biomerieux, Marcy l\'Eoile, France). After profile result evaluation, cultures identified as*Salmonella* spp. were stored at −20°C for further serotyping tests.

*Salmonella* spp.-specific real-time PCR {#sec2-4}
----------------------------------------

In order to prepare the template to be used in RT-PCR, we extracted crude DNA from control strains, and *Salmonella* isolates as indicated by [@B4]. Shortly, 1 mL frozen culture was thawed and following the centrifugation (4 min at 4,600×g) (MicroCL 17, Thermo Scientific, Waltham, MA, USA) the pellet was washed in 0.85% saline and suspended in 20 μL of deionized water, which was then boiled at 95°C on a block heater (DB-2D-FDB02DD, Techne, Staffordshire, UK) for 10 min and centrifuged for 3 min at 18,000×g. In order to confirm suspected *Salmonella* colonies, two microliters of the supernatant were used as a template in RT-PCR.

We used the *Salmonella ttr*RBCA locus-based primer pair and the target probe with previously determined specificity and sensitivity by [@B33]. Additionally, we designed the *Escherichia coli* Lambda phage-specific Internal Amplification Control (IAC) with its specific primers and probe in this study (Way2Gene, BN 15-0001-01, Genmar, Turkey) ([Table 1](#T1){ref-type="table"}). The reaction volume and cycling parameters of the modified RT-PCR was based on a protocol indicated by [@B32] using Light Cycler 2.0 (03531414201, Roche Diagnostics, Basel, Switzerland) are as follows: The 10 μL reaction mix (Way2Gene, BN 15-0001-01, Genmar, Istanbul, Turkey) comprised of 2.5 μL *Salmonella* detection mix (0.5 μM of each primer and 0.25 μM each probe), 2 μL enzyme mix (0.5 U enzyme; dNTP mix, reaction buffer solution), 1 μL (approximately 100 copies) IAC template DNA, 2.5 μL template DNA (DNA for positive control and samples, PCR-grade water for negative control and 2 μL PCR-grade water. The cycling parameters started with an initial denaturation at 95°C for 11 min, which was followed by 40 cycles of 10 s denaturation at 95°C, 30 s of annealing at 58°C and 5 s of elongation at 72°C for. For the detection of fluorescence signals, 530 nm channel was used for *Salmonella* target signal and 560 nm channel was used for IAC.

###### Primers, probes, and internal amplification control sequence used for *Salmonella* spp.-specific real-time PCR

  -----------------------------------------------------------------------------------------------------------------------------------
  Designation                                     Sequence                               Positions^[1)](#TN1){ref-type="table-fn"}^
  ----------------------------------------------- -------------------------------------- --------------------------------------------
  ttr-6 (forward)                                 CTCACCAGGAGATTACAACATGG                4287--4309

  ttr-4 (reverse)                                 AGCTCAGACCAAAAGTGACCATC                4359--4381

  ttr-5 (target probe)                            FAM-CACCGACGGCGAGACCGACTTT-TAMRA       

  IAC sequence^[2)](#TN2){ref-type="table-fn"}^   **CGTCAGTGTGAAGCGGTTATAA**ATC\         
                                                  [TGCTCTTTCGCGGTATCCGTACCGAT]{.ul}\     
                                                  TTCGGTAAGGTAAACCCCGTTTT\               
                                                  **TGTTTCGCTTACGTGGCAT**                

  IAC (forward)                                   CGTCAGTGTGAAGCGGTTATAA                 

  IAC (reverse)                                   ATGCCACGTAAGCGAAACA                    

  IAC probe                                       HEX-TGCTCTTTCGCGGTATCCGTACCGAT-TAMRA   
  -----------------------------------------------------------------------------------------------------------------------------------

Positions correspond to Genbank accession no. AF282268.

The sequences marked in boldface type are the primer binding sites for IAC, and the underlined sequence is the reverse complement IAC probe binding site.

IAC, internal amplification control.

Serotyping {#sec2-5}
----------

Serological identification was applied to the isolates, which were confirmed as *Salmonella* by biotyping and RT-PCR. Serotyping was performed by using O- and H- group specific antigens, according to the White-Kauffmann-Le Minor Scheme ([@B17]), [@B18] and [@B26] using commercial antisera (Becton Dickinson, Franklin Lakes, NJ, USA). Slide agglutination test was utilized for the analysis of somatic antigens, while the flagellar phase antigens were assessed by using the tube agglutination test.

Antimicrobial susceptibility test {#sec2-6}
---------------------------------

In selection of the antimicrobials to be tested on the isolates, [@B13] and TFC Regulation ([@B47]) recommendations were taken into consideration. Thus, 18 frequently used antimicrobials in veterinary and/or human medicine were used for testing the antimicrobial susceptibility of the isolates ([Table 2](#T2){ref-type="table"}). As the preparation step for the antimicrobial susceptibility test, a loopful of the *Salmonella* frozen stock culture was streaked onto nutrient (N, CM0003, Oxoid) agar (NA) and incubated at 37°C for 24 h. A 1--1.5 colony grown on NA was suspended in 5 mL 0.85% NaCl and streaked onto Mueller-Hinton (MH, CM0337, Oxoid) agar by 3-way streaking after adjusting the turbidity to 0.5 McFarland (Densimat, 21250, Biomerieux) and incubated for 16--20 h at 35°C ([@B14]). Plates were examined in order to categorize the isolates as susceptible (S) and resistant (R) based on the complete inhibition zone diameters and the results were interpreted by comparing the zone diameter limit values given in EUCAST ([@B13]).

###### Antimicrobials used in this study for testing susceptibility of the isolates

  NO   Name (Abbreviation, quantity on disk, catalog no)^[1)](#TN4){ref-type="table-fn"}^
  ---- ------------------------------------------------------------------------------------
  1    Amikacin (AK, 30 μg, CT0107B)
  2    Amoxicillin/clavulanic acid (AMC, 30 μg, CT0223B)
  3    Ampicillin (AMP, 10 μg, CT0003B)
  4    Ampicillin/sulbactam 1:1 (SAM, 20 μg, CT0520B)
  5    Azithromycin (AZM, 15 μg, CT0906B)
  6    Ciprofloxacin (CIP, 1 μg, CT0623B)
  7    Cefepime (FEP, 30 μg, CT0771B)
  8    Cefotaxime (CTX, 30 μg, CT0166B)
  9    Cefoxitin (FOX, 30 μg, CT0119B)
  10   Chloramphenicol (C, 30 μg, CT0013B)
  11   Ertapenem (ETP, 10 μg, CT1761B)
  12   Gentamicin (CN, 120 μg, CT0794B)
  13   Norfloxacin (NOR, 10 μg, CT0434B)
  14   Pefloxacin (PEF, 5 μg, CT0661B)
  15   Piperacillin/tazobactam (TZP, 110 μg, CT0725B)
  16   Sulphamethoxazole/trimethoprim 19:1 (SXT, 25 μg, CT0052B)
  17   Tigecycline (TGC, 15 μg, CT1841B)
  18   Tobramycin (TOB, 10 μg, CT0056B)

All disks had the same brand as Oxoid.

Statistical analysis {#sec2-7}
--------------------

Using the protocol by ISO 16140 ([@B25]), sensitivity for ISO and RT-PCR, relative trueness (RT) and the false positive ratio (FPR) of RT-PCR based on sample type were determined. Cohen's kappa test ([@B29]) was used in order to assess the accuracy of the agreement between ISO and RT-PCR results.

Results {#sec3}
=======

Overall *Salmonella* prevalence was 5% (10/200) in all the sheep examined regardless of the sample type. On the basis of sample type, 2% (4/200) of the fecal contents, and 1.5% (3/200), of both mesenteric lymph node and kidney samples were found to harbor *Salmonella*. There was no *Salmonella* isolation from the carcass, liver, spleen, or gallbladder samples. The contamination rate in all 1,400 samples was 0.7% (10/1,400) ([Table 3](#T3){ref-type="table"}).

###### Prevalence, serovar distribution and antimicrobial resistance profile of *Salmonella* in slaughter sheep

  Sample type (n)               Number of positive samples (%)   Sample ID       Serovar     Resistance profile
  ----------------------------- -------------------------------- --------------- ----------- --------------------
  Carcass (200)                 0 (0.0)                                                      
  Fecal content (200)           4 (2.0)                          F111            Newport     TGC
  F112                          Newport                          \-                          
  F214                          Newport                          PEF                         
  F247                          Typhimurium                      TGC, SXT                    
  Mesenteric lymph node (200)   3 (1.5)                          M116            Newport     TOB
  M247                          Umbilo                           \-                          
  M248                          Typhimurium                      FEP, TGC, SXT               
  Liver (200)                   0 (0.0)                                                      
  Kidney (200)                  3 (1.5)                          K42             Corvallis   AMP, CIP, NOR, PEF
  K192                          Kentucky                         \-                          
  K267                          Kentucky                         \-                          
  Spleen (200)                  0 (0.0)                                                      
  Gallbladder (200)             0 (0.0)                                                      
  Total (1,400)                 10 (0.7)                                                     

When the *Salmonella* confirmation results using RT-PCR and the ISO reference method from suspected isolates of various sample types were compared, only 2 and 5 false positives in the carcass and fecal content samples, respectively, yielded high confirmation rates in the RT for RT-PCR of 92% and 80.8%, respectively, which led to substantial agreement between RT-PCR and the ISO methods. Also, there was no false positivity in RT-PCR of suspected *Salmonella* isolates obtained from mesenteric lymph nodes and kidneys. This result suggested that RT-PCR was in perfect agreement with ISO (RT: 96%) to detect *Salmonella* from MLN samples. In addition, the test was in substantial agreement with ISO (93.8%) to identify *Salmonella* from kidney samples. Overall, when compared to ISO, the RT-PCR had 93.6% RT to detect suspected *Salmonella* isolates. This result points out that, overall, there was a substantial agreement between methods (Data not shown).

Study findings revealed the predominant serovar as *S*. Newport, since in total 40% (4/10 isolates; all 3 fecal content, and 1 out of 3 mesenteric lymph node) of the isolates were identified under this serotype. One fecal content isolate (25%) and one mesenteric lymph node (33.3%) isolate was found to be *S*. Typhimurium, while there were two *S*. Kentucky (1/3, 33.3%) isolates, both of which were isolated from kidneys. Overall, *S*. Typhimurium and *S*. Kentucky were the second-most dominant serovars (20%) within all isolates in the study. There was one *S*. Umbilo isolation from a mesenteric lymph node, and one *S*. Corvallis isolation from a kidney sample, bringing the overall isolation rates for these serovars to 10% ([Table 3](#T3){ref-type="table"}).

Antimicrobial resistance data of this study showed that 6 out of 10 (60%) salmonellae \[3 of 4 *S*. Newport (F111, F214, M116), both *S*. Typhimurium (F247, M248), and one *S*. Corvallis (K42)\] were resistant to one or more of the 18 antimicrobials. In contrast, *S*. both Kentucky isolates from kidney samples (K192, K267), one *S*. Umbilo isolate from mesenterial lymph node (M247) and the remaining *S*. Newport fecal content isolate (F112) were found as pansusceptible (40%) to all antimicrobials tested. Overall, 3 out of 6 resistant serovar isolates were MDR (50%), where *S*. Typhimurium and *S*. Corvallis (30%) showed multiresistance as follows: both *S*. Typhimurium were MDR to TGC/SXT, with one isolate\'s additional resistance to FEP, while MDR of *S*. Corvallis was AMP/CIP/NOR/PEF ([Table 3](#T3){ref-type="table"}).

Discussion {#sec4}
==========

Within farm animals, *Salmonella* prevalence is mostly studied in poultry, as it is indicated to be the primary source of infection in foodborne salmonellosis in humans. In comparison, less information is available in the current literature on this pathogen in other possible carriers, such as sheep, particularly in Turkey. Therefore, in this study we mainly aimed to determine the *Salmonella* carrier status of slaughter sheep in our country by internationally accepted standard methods with a further focus on the determination of the serogroup/serotype and/or antimicrobial resistance of the isolates.

In this study, there was no *Salmonella* isolation from carcasses ([Table 3](#T3){ref-type="table"}). This lack of finding may be related to the slaughter being applied in monorail conveyors, the inverted de-pelting procedure involving injection of compressed air under the skin, and transfer of the carcass as a whole to cold storage, all of which contribute to less handling and lower microbial contamination. Additionally, there was less fecal contamination risk during evisceration due to the natural pellet form of sheep feces, which does not stick and smear to the carcass. Previous studies have indicated the absence ([@B28]; [@B39]) or presence ([@B9]; [@B42]; [@B45]) of *Salmonella* in sheep carcasses. Differences observed in prevalence rates in these studies were reported to arise from the general hygiene status of slaughterhouses; whether slaughtering is applied in monorail conveyors or on the floor; sheep\'s initial pathogen carriage rate, increasing risk of shedding during transport stress leading to higher fecal contamination of carcass, and differences in sensitivity of *Salmonella* detection procedures. Our study results indicated that the fecal contents of apparently healthy slaughter sheep carried *Salmonella* ([Table 3](#T3){ref-type="table"}). Similar *Salmonella* contamination rates were reported in fecal contents as 3% by [@B5] in Greece, 3.6% by [@B53] in Australia, and 6.08% by [@B20] and [@B19] in Spain. In Qatar, [@B42] found a contamination rate of 22.5% in fecal content samples by PCR and attributed this finding to high cross-contamination between carcasses, poor sanitary handling by workers and equipment in the slaughterhouse. Likewise, [@B28] from Ethiopia linked their high *Salmonella* contamination rate of 11.36% in the fecal contents of sheep to their close contact during transport and prolonged holding time before slaughter. Our *Salmonella* prevalence from mesenteric lymph nodes, which correlates with the isolation rate from fecal content, is in concordance with the previous 3.85% rate of [@B19] from the USA. Additionally, there are studies from Ethiopia indicating considerably higher rates of 6.19% ([@B43] and 13.6% ([@B28]. Examination of the edible offal (liver, kidney, and spleen), and gallbladder indicated that only kidney samples (1.5%) were contaminated with *Salmonella*. Within studies on *Salmonella* prevalence in internal organs of sheep, we came across only one study, by [@B31], that sampled from kidneys, reporting an overall prevalence of 3.1% (from liver, spleen and kidney samples). The detection of *Salmonella* from this sample type in our study indicates the requirement to examine kidneys as reservoirs for this pathogen and generates data for further research. Mainly, its common consumption as \'rare grilled\' in Turkey poses a risk for salmonellosis. Additionally, contrary to our findings, there are previous studies indicating the presence of *Salmonella* at 2.0%--4.3% in liver, 3.0% in gallbladder, and 0%--1.0%in spleen ([@B28]; [@B36]; [@B52]; [@B55]).

There was only one common isolation from the fecal content (F247) and mesenteric lymph node (M247) of the same sheep, which indicated that this type of common isolation is not rare and can be caught only under exceptional conditions. Reasons for this rare common isolation may be mainly related to (1) the sheep\'s carrier state at the time of sampling; (2) sample type (e.g., carcass may not be contaminated with feces carrying the bacterium; therefore, only feces and/or the lymph node can be positive); (3) sampling and/or isolation method (although standard and proper sampling and isolation was applied, it may not always be the optimum condition for the pathogen to survive); and (4) host/strain related factors affecting isolate/serovar\'s survival (e.g., viable but not culturable state, occurrence of more than one isolate/serovar, and competition between strains/serovars).

*S*. Newport was identified as the predominant serovar in our study regardless of the sample type, whereas *S*. Typhimurium and *S*. Kentucky were isolated at lower rates. This finding is in contrast to previous reports indicating *S*. Typhimurium to be either the predominant ([@B27]; [@B36]; [@B37]; [@B42]; [@B44]; [@B51]; [@B54]) or the second-most dominant ([@B30]; [@B43]) serovar isolated. There are only a few reports that mention *S*. Newport as the second-most dominant serovar and one of the lesser isolated serovars in sheep FC ([@B8]; [@B42]; [@B49]). Additionally, parallel to our findings, *S*. Kentucky was indicated as the second-most predominant serovar by [@B8]. Despite previous reports on the isolation of *S*. Kentucky in sheep-related samples from South Africa ([@B27]), Egypt ([@B37]), and the USA ([@B49]), there is only one study on the isolation of this serovar from a human salmonellosis case in our country ([@B7]). Interestingly, one of the serovars in this study was *S*. Umbilo isolated from mesenteric lymph nodes, and the other was *S*. Corvallis isolated from a kidney. To the best of our knowledge of the previous isolation of either of these serovars from sheep, there is one study, by [@B20], reporting *S*. Umbilo isolation from sheep feces, while there is no study indicating *S*. Corvallis detection from sheep. In our country, these two serovars were previously isolated only from human salmonellosis cases ([@B7]). The reasons behind our isolation of these 'rare serovars' from the above sample types may be mainly related to the scarcity of sheep *Salmonella* seroprevalence studies in our country. There may also be unreported isolations of these serovars, while differences in serotyping methods and technical applications, as well as changes in serovars due to geographical and physical conditions where sheep are raised would all account for these types of variations.

An additional benefit in our study is the use of both RT-PCR and ISO in the fast and accurate confirmation of suspected *Salmonella* isolated from sheep, and especially from mesenteric lymph nodes, as this was proven by an overall substantial agreement between methods (Data not shown).

Based on antibiotyping findings, more than half of the salmonellae (60%) in this study were resistant to one or more antimicrobials tested, with a 40% MDR rate ([Table 3](#T3){ref-type="table"}). Similarly, [@B10] indicated 80% resistance in their *Salmonella* isolates with 20% MDR. Within *S*. Newport isolates, all but one (75%) was resistant to only one out of 18 antimicrobials tested. Within previous literature, we could not come across a study reporting antimicrobial susceptibility of a *S*. Newport isolated from sheep. Thus, we were unable to discuss the resistance profiles of these isolates to any earlier relevant data. Both of the *S*. Typhimurium isolates were MDR to TGC and SXT, with one additional resistance to FEP. Formerly, SXT resistance and susceptibility of this serovar were reported by [@B36] and [@B40], respectively. Additionally, the AMP, AMC, C, CIP, AK, FOX, and CN susceptibility of the*S*. Typhimurium serovar isolated from the fecal content was indicated by [@B36] and [@B40]. Two *S*. Kentucky isolates from kidney samples were pansusceptible to all of the antimicrobials tested. In a study by [@B8], where 8.8% of isolated salmonellae were found resistant, the *S*. Kentucky isolate was susceptible to AMC, AMP, AZM, FOX, C, CIP, CN, and SXT. Similar to our *S*. Kentucky isolates, the *S*. Umbilo serovar isolated from mesenteric lymph nodes was also susceptible to all antimicrobials tested, parallel to an earlier finding by [@B20]. Another serovar isolated in our study was *S*. Corvallis, with an AMP/CIP/NOR/PEF resistance profile, which indicated that this serovar showed resistance to all fluoroquinolones tested. We were not able to directly compare this unique result of *S*. Corvallis isolation from sheep and its high MDR, since we could not come across relevant data in the past studies. However, one possible source for this resistant serovar in sheep could be related to poultry (a source for transmission if sheep and poultry are bred in close contact), since poultry is an important reservoir for fluoroquinolone resistant *S*. Corvallis ([@B50]).

Conclusion {#sec5}
==========

Contaminated carcass, fecal content, mesenterial lymph nodes and edible offal of apparently healthy slaughter sheep carrying NTS is of significant health risk to public in Turkey, where ovine meat covers the second highest annual red meat consumption quota with high demand to edible offal. In this study, current predominance of *S*. Newport, particularly in fecal contents; the presence of *S*. Typhimurium and Kentucky as the second dominant serovars; detection of *S*. Corvallis for the first time in sheep in the world, first time isolations of Newport, Kentucky, Corvallis, Umbilo serovars from sheep in Turkey; and high antimicrobial resistance rates obtained in more than half of the isolates showing 20% MDR highlights the findings of this study. Isolation of such diverse and antimicrobial resistant serovars from healthy sheep indicates its non-negligible reservoir and shedding capacity of *Salmonella* to the environment. Hence, the inclusion of sheep in national-based *Salmonella* surveys for safer food production and processing lines is strongly recommended.
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